SOW
ESPR

State of Wyoming’s Esperion Therapeutics ESPR Stock Holding History

State of Wyoming’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-105,182
Closed -$288K – 2005
2026
Q1 		$288K Buy
105,182
+41,830
+66% +$132K 0.03% 692
2025
Q4 		$234K Buy
+63,352
New +$205K 0.03% 851
2025
Q3 		– Sell
-122,532
Closed -$121K – 1898
2025
Q2 		$121K Buy
122,532
+32,596
+36% +$32.6K 0.01% 1209
2025
Q1 		$130K Buy
89,936
+43,526
+94% +$80.2K 0.02% 1035
2024
Q4 		$102K Sell
46,410
-31,390
-40% -$73.2K 0.01% 1176
2024
Q3 		$128K Buy
77,800
+12,084
+18% +$24.4K 0.02% 978
2024
Q2 		$146K Buy
+65,716
New +$155K 0.02% 802
2022
Q2 		– Sell
-10,894
Closed -$51K – 1945
2022
Q1 		$51K Buy
+10,894
New +$46.7K 0.03% 1044

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

State of Wyoming's ESPR Position: Q2 2026 in Review

State of Wyoming sold out of Esperion Therapeutics (ESPR) in Q2 2026, closing a stake of 105,182 shares — an estimated $288K sold.

State of Wyoming first reported a position in ESPR in Q1 2022 and held it in 8 quarters. The position peaked at $288K in Q1 2026. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • State of Wyoming reported no remaining Esperion Therapeutics position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 105,182 Esperion Therapeutics shares in Q2 2026, an estimated $288K.
  • State of Wyoming first reported a position in Esperion Therapeutics in Q1 2022 and held it in 8 quarters.
  • State of Wyoming's Esperion Therapeutics position peaked at $288K in Q1 2026.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.